Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
| ▸ | ESR1 | P03372 | 1/20 | 0.74 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.74 |
| ▸ | LTA4H | P09960 | 6/20 | 0.61 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.61 |
| ▸ | BAX | Q07812 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9657433 | 1.00 | MEN1 (0.74) | MEN1KMT2AESR1ESR2LTA4H | |
| Methoxymethane SCHEMBL9362764 | 0.93 | LTA4H (0.64) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL9503528 | 0.93 | ESR2 (0.64) | MEN1KMT2AESR1ESR2LTA4H | |
| Diphenylether SCHEMBL9751425 | 0.88 | LTA4H (0.74) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL249169 | 0.86 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL3175106 | 0.86 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL18198 | 0.86 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL457634 | 0.86 | MAOA (0.74) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL7811939 | 0.86 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL9242729 | 0.86 | MAOA (0.74) | MEN1KMT2AESR1ESR2LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114621175-B | Difenoconazole hapten, artificial antigen, antibody and preparation method and application thereof | 华南农业大学 | 2023-06-27 | — | — | CN | claimed |
| CN-114621175-A | Difenoconazole hapten, artificial antigen, antibody and preparation method and application thereof | 华南农业大学 | 2022-06-14 | — | — | CN | claimed |
| CN-106554382-B | Application in nucleoside phosphoramidite class compound and preparation method thereof and drug | 四川科伦博泰生物医药股份有限公司 | 2019-12-03 | — | — | CN | claimed |
| WO-2011011598-A1 | PROCESS FOR PREPARING 4- { (S) -2- (4-(4-CHLOROPHENOXY) PHENOXYMETHYL) PYRROLIDIN-1-YL) } BUTYRIC ACID AND SALTS THEREOF | DECODE GENETICS EHF (IS) | 2011-01-27 | — | — | WO | claimed |
| EP-1664027-A1 | SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE | AMGEN INC. (US) | 2006-06-07 | — | — | EP | claimed |
| WO-2005021532-A1 | SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE | AMGEN INC (US) | 2005-03-10 | — | — | WO | claimed |
| EP-0306051-B1 | Process for production of aromatic polyethers | MITSUBISHI GAS CHEMICAL CO (JP) | 1996-03-06 | — | — | EP | claimed |
| EP-0306051-A1 | Process for production of aromatic polyethers | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1989-03-08 | — | — | EP | claimed |
| US-20250197840-A1 | ENGINEERED ENZYMES AND BIOPRODUCTION OF BAKUCHIOL | INSCRIPTA, INC. | 2025-06-19 | — | — | US | disclosed |
| US-12195775-B2 | Engineered enzymes and bioproduction of bakuchiol | INSCRIPTA, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| EP-4486905-A1 | ENGINEERED ENZYMES AND BIOPRODUCTION OF BAKUCHIOL | Inscripta, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| WO-2024119440-A1 | BIODEGRADABLE MULTI-BLOCK COPOLYMERS COMPRISING LINKING UNITS DERIVED FROM CYCLIC KETENE ACETAL | BASF SE (DE) | 2024-06-13 | — | — | WO | disclosed |
| CN-118090684-A | Reagent and method for rapid colorimetric fluorescence detection of mercury ions, iron ions, copper ions and zinc ions | 石河子大学 | 2024-05-28 | — | — | CN | disclosed |
| US-20240101614-A1 | CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS | INSCRIPTA, INC. (US) | 2024-03-28 | — | — | US | disclosed |
| US-4156011-A | TREATMENT OF CARDIOVASCULAR DISORDERS | SOCIETE ANONYME DITE: LABORATOIRE L. LAFON (FR) | 1979-05-22 | — | — | US | disclosed |
| US-4072754-A | ANTICHOLESTEROL | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-02-07 | — | — | US | disclosed |
| US-4051173-A | Phenoxyalkanol derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-09-27 | — | — | US | disclosed |
| US-4051170-A | Diphenoxyacetic acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-09-27 | — | — | US | disclosed |
| US-3985875-A | RENIN INHIBITION, ANTIHYPERTENSIVE, ANTICHOLESTEROL AGENTS | DAINIPPON PHARMACEUTICAL CO., LTD. (JA) | 1976-10-12 | — | — | US | disclosed |
| US-3954442-A | 4-PHENOXY-PHENOXY-ALKANE-CARBOXYLIC ACIDS AND DERIVATIVES | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101614-A1 | CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS | HSPA5, HSPA8, HSP90B1 | MEN1 4460/4885KMT2A 3990/4885ESR1 3838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.